🔎 Trials Near Me

Home › Thyroid Cancer › Pennsylvania › Philadelphia

Thyroid Cancer clinical trials in Philadelphia, PA

6 studies for Thyroid Cancer are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RecruitingObservational studyHealthy volunteers welcome
  • Reading Hospital McGlinn Cancer Institute at Phoenixville, Phoenixville · 22 mi away
Ages 40 to 75 · All sexes · Updated Oct 2, 2026 · NCT05334069

DESTINY-PANTUMOUR04

RecruitingObservational study
  • Research Site, Philadelphia
Ages 18 to 130 · All sexes · Updated Sep 25, 2026 · NCT07124000

Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)

RecruitingPhase 2
  • Children's Hospital of Philadelphia, Philadelphia
Ages 2 to 25 · All sexes · Updated Jul 24, 2026 · NCT06458036

Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer

RecruitingPhase 2
  • Children's Hospital of Philadelphia, Philadelphia
Ages 2 to 99 · All sexes · Updated Nov 14, 2025 · NCT05783323

Assessing Patient Satisfaction and Confidence After Use of Educational Video to Augment Surgical Consent for Thyroid Surgery

Recruiting
  • Thomas Jefferson University, Philadelphia
Ages 18 and older · All sexes · Updated Apr 13, 2025 · NCT06918223

Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC

RecruitingPhase 2
  • Children's Hospital of Philadelphia, Philadelphia
Ages 12 and older · All sexes · Updated Dec 12, 2024 · NCT05668962

About Thyroid Cancer

Your thyroid is a butterfly-shaped gland in your neck. There are several thyroid cancer types with different treatments. Discover options available.

More about Thyroid Cancer on MedlinePlus

Thyroid Cancer trials in other cities

Other studies in Philadelphia

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.